Zwitserland - Italiaans - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - sitagliptinum - compresse rivestite con film - sitagliptinum 100 mg ut sitagliptini malas, cellulosum microcristallinum, calcii hydrogenophosphas, carmellosum natricum conexum, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, e 171, e 172 (flavum), e 172 (rubrum), pro compresso obducto corresp. natrium 1.04 mg. - farmaco antidiabetico orale - synthetika

Zwitserland - Italiaans - Swissmedic (Swiss Agency for Therapeutic Products)

axapharm ag - sitagliptinum - compresse rivestite con film - sitagliptinum 25 mg ut sitagliptini hydrochloridum monohydricum, cellulosum microcristallinum, calcii hydrogenophosphas, carmellosum natricum conexum, natrii stearylis fumaras, magnesii stearas, Überzug: poly(vinylis acetas), e 171, macrogola, talcum, e 172 (flavum), e 172 (rubrum), pro compresso obducto corresp. natrium 0.28 mg. - farmaco antidiabetico orale - synthetika

Zwitserland - Italiaans - Swissmedic (Swiss Agency for Therapeutic Products)

axapharm ag - sitagliptinum - compresse rivestite con film - sitagliptinum 50 mg ut sitagliptini hydrochloridum monohydricum, cellulosum microcristallinum, calcii hydrogenophosphas, carmellosum natricum conexum, natrii stearylis fumaras, magnesii stearas, Überzug: poly(vinylis acetas), e 171, macrogola, talcum, e 172 (flavum), e 172 (rubrum), pro compresso obducto corresp. natrium 0.56 mg. - farmaco antidiabetico orale - synthetika

Zwitserland - Italiaans - Swissmedic (Swiss Agency for Therapeutic Products)

axapharm ag - sitagliptinum - compresse rivestite con film - sitagliptinum 100 mg ut sitagliptini hydrochloridum monohydricum, cellulosum microcristallinum, calcii hydrogenophosphas, carmellosum natricum conexum, natrii stearylis fumaras, magnesii stearas, Überzug: poly(vinylis acetas), e 171, macrogola, talcum, e 172 (flavum), e 172 (rubrum), pro compresso obducto corresp. natrium 1.12 mg. - farmaco antidiabetico orale - synthetika

Zwitserland - Italiaans - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - sitagliptinum - compresse rivestite con film - sitagliptinum 25 mg ut sitagliptini hydrochloridum monohydricum 28.34 mg, cellulosum microcristallinum, calcii hydrogenophosphas, carboxymethylamylum natricum a, magnesii stearas, Überzug: poly(alcohol vinylicus), e 171, macrogola, talcum, e 172 (flavum), e 172 (rubrum), pro compresso obducto corresp. natrium 1.125 mg. - farmaco antidiabetico orale - synthetika

Zwitserland - Italiaans - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - sitagliptinum - compresse rivestite con film - sitagliptinum 50 mg ut sitagliptini hydrochloridum monohydricum 56.69 mg, cellulosum microcristallinum, calcii hydrogenophosphas, carboxymethylamylum natricum a, magnesii stearas, Überzug: poly(alcohol vinylicus), e 171, macrogola, talcum, e 172 (flavum), e 172 (rubrum), e 172 (nigrum), pro compresso obducto corresp. natrium 2.25 mg. - farmaco antidiabetico orale - synthetika

Zwitserland - Italiaans - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - sitagliptinum - compresse rivestite con film - sitagliptinum 100 mg ut sitagliptini hydrochloridum monohydricum 113.38 mg, cellulosum microcristallinum, calcii hydrogenophosphas, carboxymethylamylum natricum a, magnesii stearas, Überzug: poly(alcohol vinylicus), e 171, macrogola, talcum, e 172 (flavum), e 172 (rubrum), pro compresso obducto corresp. natrium 4.5 mg. - farmaco antidiabetico orale - synthetika

Zwitserland - Italiaans - Swissmedic (Swiss Agency for Therapeutic Products)

spirig healthcare ag - sitagliptinum, metformini hydrochloridum - compresse rivestite con film - sitagliptinum 50 mg ut sitagliptini hydrochloridum monohydricum, metformini hydrochloridum 500 mg, cellulosum microcristallinum, povidonum k 29-32, natrii laurilsulfas, natrii stearylis fumaras, Überzug: poly(alcohol vinylicus), e 171, macrogolum, talcum, e 172 (flavum), e 172 (rubrum), pro compresso obducto corresp. natrium 1.03 mg. - il diabete mellito di tipo 2 - synthetika

Zwitserland - Italiaans - Swissmedic (Swiss Agency for Therapeutic Products)

spirig healthcare ag - sitagliptinum, metformini hydrochloridum - compresse rivestite con film - sitagliptinum 50 mg ut sitagliptini hydrochloridum monohydricum, metformini hydrochloridum 850 mg, cellulosum microcristallinum, povidonum k 29-32, natrii laurilsulfas, natrii stearylis fumaras, Überzug: lactosum monohydricum 13.7 mg, hypromellosum, e 171, triacetinum, e 172 (rubrum), pro compresso obducto corresp. natrium 1.74 mg. - il diabete mellito di tipo 2 - synthetika

Zwitserland - Italiaans - Swissmedic (Swiss Agency for Therapeutic Products)

spirig healthcare ag - sitagliptinum, metformini hydrochloridum - compresse rivestite con film - sitagliptinum 50 mg ut sitagliptini hydrochloridum monohydricum, metformini hydrochloridum 1000 mg, cellulosum microcristallinum, povidonum k 29-32, natrii laurilsulfas, natrii stearylis fumaras, Überzug: poly(alcohol vinylicus), e 171, macrogolum, talcum, e 172 (rubrum), e 172 (nigrum), pro compresso obducto corresp. natrium 2.02 mg. - il diabete mellito di tipo 2 - synthetika